• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS T4 ASSAY; RADIOIMMUNOASSAY, TOTAL THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS T4 ASSAY; RADIOIMMUNOASSAY, TOTAL THYROXINE Back to Search Results
Catalog Number ASKU
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/08/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(6).(b)(4).
 
Event Description
The customer complained of high results for 1 patient sample tested for elecsys ft4 ii assay (ft4 ii) and elecsys ft3 iii (ft3 iii) on a cobas 6000 e 601 module.The initial ft3 iii and ft4 ii results were reported outside of the laboratory where the physician complained that the results did not correspond to the patient's clinical picture.The sample was sent for testing by the abbott method along with repeat testing with an edta plasma sample on the customer's e601 module and repeat testing on another hospitals e601 module.Based on the data provided, discrepant results were identified for ft4 ii, ft3 iii, elecsys t3 (t3) and elecsys t4 assay (t4).Refer to medwatches with the following patient identifiers for the assays involved: (b)(6).There was no allegation that an adverse event occurred.The customer's e601 serial number was (b)(4).The e601 serial number used at the external laboratory was not provided.
 
Manufacturer Narrative
Upon further investigation of the patient sample, an interferent against a component of the reagent was confirmed.This caused the high ft4 ii, ft3 iii, t3 and t4 results.This interference is covered in product labeling.Product labeling states "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS T4 ASSAY
Type of Device
RADIOIMMUNOASSAY, TOTAL THYROXINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7300026
MDR Text Key101509598
Report Number1823260-2018-00587
Device Sequence Number1
Product Code CDX
Combination Product (y/n)N
PMA/PMN Number
K961490
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 03/20/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/27/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberASKU
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Date Manufacturer Received02/08/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-